"We remain focused on continuing to enhance the value of our innovative and established businesses," Pfizer CEO Ian Read said in a statement.
Allergan, Pfizer call off proposed $160B merger →
"There are people who are falling through the cracks through no fault of their own," Read said. "As a stopgap, we're willing to do this."
Pfizer doubling patient income limit for free drug program →